yohimbine has been researched along with Obesity in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (22.22) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bilska-Wilkosz, A; Górny, M; Iciek, M; Kaczor-Kamińska, M; Kotańska, M; Zagajewski, J | 1 |
| Liu, X | 1 |
| Bednarski, M; Dudek, M; Głuch-Lutwin, M; Kazek, G; Knutelska, J; Mordyl, B; Nowiński, L; Pytka, K; Sapa, J; Zygmunt, M | 1 |
| Blankenship, MM; Bloomer, RJ; Canale, RE; Fisher-Wellman, KH; Hammond, KG; Schilling, BK | 1 |
| Jordan, J; Sharma, AM | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 1 |
| Ernst, E; Pittler, MH | 1 |
| Bissoon, L; Caruso, MK; Greenway, FL; Guillot, TS; Roberts, AT; Self, KS | 1 |
| Hoffman, BB; Lefkowitz, RJ; Tharp, MD | 1 |
| Kather, H; Müller, P; Rittinghausen, R; Simon, B | 1 |
| Berlan, M; Carpene, C; Dang-Tran, L; Lafontan, M | 1 |
| Arner, P; Large, V; Lönnqvist, F; Reynisdottir, S; Thörne, A; Van Harmelen, V; Wennlund, A | 1 |
| Hartleb, M; Janusz, M; Karpel, E; Nowak, A; Waluga, M | 1 |
| Calzoni, F; Ceroni, L; Cortelli, P; Gambineri, A; Gnudi, U; Menozzi, R; Pasquali, R; Rio, GD; Sinisi, R; Vicennati, V | 1 |
| Buemi, M; Corica, F; Corsonello, A; De Domenico, D; Ientile, R; Malara, A | 1 |
| Montastruc, JL; Pelat, M; Senard, JM; Tran, MA; Verwaerde, P | 1 |
| Chan, CB; MacPhail, RM | 1 |
| Currie, PJ; Wilson, LM | 1 |
| Okuda, T; Romsos, DR; Tassava, TM | 1 |
| Fujioka, S; Kawamoto, T; Keno, Y; Kobatake, T; Matsuzawa, Y; Tarui, S; Tokunaga, K; Watanabe, Y; Yoshida, H | 1 |
| Jonderko, K; Kucio, C | 1 |
| Berlan, M; Flores, R; Foureau, M; Galitzky, J; Houin, G; Lafontan, M; Louvet, JP; Riviere, D; Tran, MA | 1 |
| Jonderko, K; Kucio, C; Piskorska, D | 1 |
| Sax, L | 1 |
| Kucio, C; Piskorska, D; Zahorska-Markiewicz, B | 2 |
| Bégin-Heick, N; Welsh, J | 1 |
1 review(s) available for yohimbine and Obesity
| Article | Year |
|---|---|
Complementary therapies for reducing body weight: a systematic review.
Topics: Acupuncture Therapy; Complementary Therapies; Dietary Supplements; Homeopathy; Humans; Hypnosis; Iron Chelating Agents; Obesity; Phytotherapy; Plant Preparations; Pyruvates; Weight Loss; Yohimbine | 2005 |
5 trial(s) available for yohimbine and Obesity
| Article | Year |
|---|---|
Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study.
Topics: Adipose Tissue; Analysis of Variance; Anti-Obesity Agents; Area Under Curve; Biomarkers; Caffeine; Catecholamines; Complex Mixtures; Cross-Over Studies; Dietary Supplements; Energy Intake; Energy Metabolism; Epinephrine; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Lipolysis; Male; Norepinephrine; Obesity; Physical Fitness; Surveys and Questionnaires; Synephrine; Yohimbine; Young Adult | 2009 |
Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients.
Topics: Adult; Double-Blind Method; Energy Metabolism; Ephedrine; Female; Gamma Cameras; Gastric Emptying; Humans; Male; Microspheres; Obesity; Serum Albumin; Technetium; Yohimbine | 1991 |
Does yohimbine act as a slimming drug?
Topics: Adult; Combined Modality Therapy; Diet, Reducing; Double-Blind Method; Energy Metabolism; Exercise; Female; Gastric Emptying; Glycerol; Humans; Lipolysis; Middle Aged; Norepinephrine; Obesity; Rest; Yohimbine | 1991 |
Yohimbine does not affect fat distribution in men.
Topics: Adipose Tissue; Administration, Oral; Adult; Analysis of Variance; Body Mass Index; Double-Blind Method; Humans; Lipolysis; Male; Middle Aged; Obesity; Patient Compliance; Skinfold Thickness; Tomography, X-Ray Computed; Weight Loss; Yohimbine | 1991 |
[Use of yohimbine, an alpha-adrenolytic drug, in obesity].
Topics: Adult; Clinical Trials as Topic; Female; Humans; Lipolysis; Middle Aged; Obesity; Yohimbine | 1986 |
21 other study(ies) available for yohimbine and Obesity
| Article | Year |
|---|---|
Yohimbine Alleviates Oxidative Stress and Suppresses Aerobic Cysteine Metabolism Elevated in the Rat Liver of High-Fat Diet-Fed Rats.
Topics: Animals; Cysteine; Diet, High-Fat; Liver; Male; Obesity; Oxidative Stress; Rats; Sulfur; Sulfur Compounds; Thiosulfate Sulfurtransferase; Yohimbine | 2023 |
Enhanced motivation for food reward induced by stress and attenuation by corticotrophin-releasing factor receptor antagonism in rats: implications for overeating and obesity.
Topics: Animals; Conditioning, Operant; Dietary Fats; Food; Hyperphagia; Male; Motivation; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reinforcement Schedule; Reward; Satiation; Stress, Psychological; Sympatholytics; Yohimbine | 2015 |
A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Appetite Depressants; Body Weight; Diet, High-Fat; Guanfacine; Heart Rate; Humans; Ligands; Obesity; Rats; Receptors, Adrenergic, alpha-2; United States; Yohimbine | 2015 |
Potential for sibutramine-yohimbine interaction?
Topics: Animals; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyclobutanes; Drug Interactions; Humans; Hypertension; Obesity; Tachycardia; Yohimbine | 2003 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite.
Topics: Adipocytes; Adipose Tissue; Aminophylline; Cells, Cultured; Drug Evaluation, Preclinical; Glycerol; Humans; Injections, Subcutaneous; Isoproterenol; Lipolysis; Melilotus; Obesity; Plant Extracts; Yohimbine | 2008 |
alpha-Adrenergic receptors in human adipocyte membranes: direct determination by [3H]yohimbine binding.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adult; Aged; Binding, Competitive; Female; Humans; Kinetics; Middle Aged; Obesity; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Tritium; Yohimbine | 1981 |
[Yohimbine: renaissance of an old medicine?].
Topics: Adrenergic alpha-Antagonists; Energy Metabolism; Humans; Lipid Mobilization; Medicine, Traditional; Obesity; Platelet Aggregation; Thyroid Hormones; Yohimbine | 1981 |
Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
Topics: Adipose Tissue; Animals; Clonidine; Dogs; Epinephrine; Isoproterenol; Lipolysis; Obesity; Prazosin; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Theophylline; Yohimbine | 1982 |
Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Topics: Adipocytes; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Dobutamine; Dose-Response Relationship, Drug; Female; Humans; Isoproterenol; Lipolysis; Male; Mesentery; Middle Aged; Norepinephrine; Obesity; Omentum; Propanolamines; Terbutaline; Yohimbine | 1997 |
Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
Topics: Adrenergic alpha-Antagonists; Adult; Appetite Depressants; Body Mass Index; Caffeine; Cardiography, Impedance; Central Nervous System Stimulants; Diet, Reducing; Ephedrine; Exercise Test; Female; Hemodynamics; Humans; Obesity; Yohimbine | 1998 |
alpha2-adrenoceptor regulation of the hypothalamic-pituitary-adrenocortical axis in obesity.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Body Constitution; Case-Control Studies; Clonidine; Corticotropin-Releasing Hormone; Epinephrine; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Norepinephrine; Obesity; Pituitary-Adrenal System; Yohimbine | 2000 |
Effects of alpha- and beta-adrenergic stimulation on free magnesium concentrations in platelets from healthy and obese individuals.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Blood Platelets; Clonidine; Epinephrine; Humans; Insulin; Isoproterenol; Magnesium; Male; Norepinephrine; Obesity; Time Factors; Yohimbine | 2001 |
Alpha2 -adrenoceptor function in arterial hypertension associated with obesity in dogs fed a high-fat diet.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Platelets; Blood Pressure; Catecholamines; Clonidine; Diastole; Dietary Fats; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Male; Obesity; Prazosin; Receptors, Adrenergic, alpha; Systole; Yohimbine | 2002 |
Functional characterization of alpha-adrenoceptors on pancreatic islets of fa/fa Zucker rats.
Topics: Animals; Cells, Cultured; Clonidine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Epinephrine; Female; Glucose; Insulin; Islets of Langerhans; Obesity; Prazosin; Rats; Rats, Zucker; Receptors, Adrenergic, alpha; Yohimbine | 1992 |
Yohimbine attenuates clonidine-induced feeding and macronutrient selection in genetically obese (ob/ob) mice.
Topics: Animals; Clonidine; Diet; Dietary Carbohydrates; Energy Intake; Feeding Behavior; Food Preferences; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Yohimbine | 1992 |
Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.
Topics: Acetylcholine; Animals; Atropine; Epinephrine; Female; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Obesity; Yohimbine | 1992 |
Age-related changes in adrenergic alpha 1, alpha 2, and beta receptors of rat white fat cell membranes: an analysis using [3H]bunazosin as a novel ligand for the alpha 1 adrenoceptor.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aging; Animals; Binding Sites; Cell Membrane; Epididymis; Kinetics; Male; Obesity; Propanolamines; Quinazolines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Yohimbine | 1991 |
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Catecholamines; Epinephrine; Fatty Acids, Nonesterified; Female; Heart Rate; Humans; Insulin; Norepinephrine; Obesity; Propranolol; Yohimbine | 1991 |
Adrenergic control of lipolysis and metabolic responses in obesity.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Blood Glucose; Body Weight; Energy Metabolism; Epinephrine; Fatty Acids, Nonesterified; Female; Humans; Lipolysis; Obesity; Phentolamine; Yohimbine | 1986 |
The regulation of adenylate cyclase in liver membranes of lean and obese mice.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cell Membrane; Cholera Toxin; Enzyme Activation; Glucagon; Guanosine Triphosphate; Isoproterenol; Liver; Magnesium; Magnesium Chloride; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Obesity; Pertussis Toxin; Propranolol; Virulence Factors, Bordetella; Yohimbine | 1988 |